HB-2121
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HB-2121, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease [Phase 1]